INO

Inovio Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↑ 6/10
  • Momentum↓ 3/10
Inovio Pharmaceuticals sales and earnings growth
INO Growth
Good
  • Revenue Y/Y↓ -10.36%
  • EPS Y/Y↑ 42.06%
  • FCF Y/Y↑ 19.82%
Inovio Pharmaceuticals gross and profit margin trends
INO Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -59281.70%
  • ROIC↓ -846.50%
Inovio Pharmaceuticals net debt vs free cash flow
INO Risk
Great
  • Debt / Equity↓ -1.3
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Inovio Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗